Neurology Flashcards
Migraine abortive therapy
• Simple analgesics (eg, NSAIDs, acetaminophen)
• Antiemetics (eg, metoclopramide, prochlorperazine)
• Triptans (eg, sumatriptan)
• Ergotamine, dihydroergotamine
• CGRP receptor antagonists (eg, rimegepant)
Migraine preventive therapy
• Antiepileptics (eg, topiramate, divalproex sodium)
• Tricyclic antidepressants (eg, amitriptyline)
• Beta blockers (eg, propranolol)
• CGRP monoclonal antibodies (eg, erenumab)
Chronic inflammatory demyelinating polyradiculoneuropathy
presents with progressive muscle weakness, distal sensory loss, and diminished or absent reflexes developing over >8 weeks.
Diagnosis is confirmed with electrodiagnostic studies demonstrating peripheral nerve demyelination.
Cerebrospinal fluid analysis will show albuminocytologic dissociation in the vast majority of cases.
Idiopathic intracranial hypertension (IIH) (ie, pseudotumor cerebri).
Presentation
Symptoms of IIH include headaches, visual symptoms, tinnitus, and diplopia.
Headaches are chronic, holo-cranial, and pulsatile in nature; they are exacerbated by lying flat and improved by sitting up.
The most important sign of IIH is papilledema, which is frequently bilateral and can lead rapidly to vision loss.
Idiopathic intracranial hypertension (IIH) (ie, pseudotumor cerebri).
Risk factors
frequently seen in young obese women, it has also been associated with certain medications (eg, isotretinoin, tetracyclines, growth hormone, and vitamin A).
Idiopathic intracranial hypertension (IIH) (ie, pseudotumor cerebri).
Diagnosis
Diagnosis of IIH includes
-complete ocular examination
-neuroimaging to exclude secondary causes of intracranial hypertension (eg, mass, hemorrhage, cerebral vein thrombosis).
*Empty sella is present in about 70% of patients with IIH but is not diagnostic.
Lumbar puncture is performed with the patient in the lateral decubitus position. An opening pressure of > 250 mm H₂O is considered abnormal.
CSF studies are normal in IIH patients.
Idiopathic intracranial hypertension (IIH) (ie, pseudotumor cerebri).
Treatment
- weight loss
- headache prophylaxis with topiramate
- acetazolamide (+/- furosemide).
Short-term treatment may involve corticosteroids and serial lumbar punctures for patients awaiting surgery for progressive visual loss.
Surgical choices include optic nerve sheath fenestration and/or CSF shunting procedures
3rd Cranial nerve palsy, Non pupil sparing
Non-pupil-sparing third nerve palsies are frequently caused by mass effect (eg, intracranial aneurysm, tumor). Aneurysms arise from vessels that have a close anatomic relationship with the third nerve (eg, posterior cerebral artery, superior cerebellar artery, posterior communicating artery). A non-pupil-sparing third nerve palsy (as seen in this patient) should be considered due to an aneurysm until proved otherwise; patients should undergo immediate MR or CT angiography for evaluation.
3rd Cranial nerve palsy, Pupil sparing
Pupil-sparing third nerve palsies are typically caused by microvascular ischemia;
they are associated with diabetes, hypertension, hyperlipidemia, and advanced age.
Observation and supportive care may be appropriate in patients with vasculopathic risk factors (eg, diabetes, hypertension),
although some physicians advocate for imaging to exclude mass effect with all third nerve palsies
Meralgia paresthetica
is due to lateral femoral cutaneous nerve (LFCN) compression
presents with pure sensory symptoms (e.g., numbness, paresthesias, and dysesthesias) in the anterolateral thigh.
Risk factors include wearing tight pants or belts, pregnancy, obesity, and diabetes.
The diagnosis is made clinically.
Patients should be reassured that this is not a serious condition, and they usually respond to conservative treatment
Thrombotic vs Embolic stroke in clinical presentation
Ischemic strokes may be caused by embolism or thrombosis.
Embolic strokes usually have an abrupt onset of focal neurologic findings with maximal symptoms at onset.
Thrombotic strokes usually present as fluctuating symptoms with periodic improvement and a stuttering progression
Brain lesions and prophylactic anti-convulsant
Current studies show prophylactic anticonvulsant medications are mainly beneficial in:
⏩⏩patients with newly diagnosed brain tumors who present with a seizure.
⏩⏩Prophylactic anticonvulsants (for 1 week with taper afterwards) are also indicated in patients who have had a craniotomy for brain tumor resection, brain MRI showing acute hemorrhage within the tumor, or significant mass effect/edema in the vicinity of the cortex.
Brain lesions management
Patients presenting with new-onset headache with focal neurologic deficits in the setting of cerebral metastatic disease should be started on intravenous steroids (e.g., methylprednisolone or dexamethasone) to reduce vasogenic edema and mass effect.
Restless leg syndrome
Manafistation
Uncomfortable urge to move legs with:
• Unpleasant sensations in the legs
• Onset with inactivity or at night
• Relief with movement (eg, walking, stretching)
Restless leg syndrome
Risk factors & associated conditions
• Iron deficiency
• Uremia
• Pregnancy
• Diabetes mellitus (especially with neuropathy)
• Multiple sclerosis, Parkinson disease
• Drugs: antidepressants, antipsychotics, antiemetics
Restless leg syndrome
Management
Non-pharmacologic Limit caffeine & alcohol Regular, moderate exercise. Warm &/or cold soaks or compresses
Pharmacologic
-Supplemental iron (if serum ferritin <75 ng/mL)
- Mild intermittent symptoms: carbidopa-levodopa as needed
• Frequent/daily symptoms: a28 calcium channel ligand (eg, gabapentin, pregabalin)
• Dopamine agonists (eg, pramipexole, ropinirole) not preferred
TIA disposition
Patients with recent (within 24-48 hours) transient ischemic attack (TIA) and risk factors:
-multiple recurrent TIAs,
-atrial fibrillation,
-symptom duration > 1 hour,
-symptomatic internal carotid artery stenosis > 50%,
-hypercoagulable disorders, or
-high ABCD² score
have higher risk of stroke within the next 48 hours. They should be hospitalized for further investigation and prevention.
Upper motor neurons signs
• Spastic paralysis
• Clasp-knife rigidity
• Hyperreflexia
• Babinski sign
Lower motor neurons signs
• Flaccid paralysis
• Hypotonia
• Hyporeflexia
• Muscle atrophy & fasciculations
Parkinson disease pharmacologic therapy
Levodopa/carbidopa: Most effective, preferred in severe disease & patients age >65 due to motor fluctuations in younger patients
Dopamine agonists: (Pramipexole) Preferred in patients age <65 & with mild to moderate disease
Anticholinergics (Trihexyphenidyl): Can be used in patients age <70 with tremor & no significant akinesia or gait disturbance
Brain death testing
When clinical criteria suggest brain death, the best next step is apnea testing. Patients must be hemodynamically stable with a body temperature > 36 C (97 F), normal pH, and normal PaCO2/PaO, levels. Apnea testing objectively confirms brainstem failure if
the patient cannot generate spontaneous breaths or trigger the ventilator in response to elevated PaCO, levels > 10 minutes after disabling control mode
Dementia with lewy bodies management
Pharmacotherapy for DLB includes cholinesterase inhibitors for cognitive impairment, melatonin for RBD, and carbidopa-levodopa for parkinsonism. Patients with DLB are extremely sensitive to antipsychotics; as a result, low-potency, second-generation antipsychotics (eg, quetiapine) should be used only for functionally impairing hallucinations or delusions.
Valproate toxicity
Valproic acid can lead to elevated serum ammonia levels resulting in encephalopathy. Patients presenting with encephalopathy on valproic acid should have their serum ammonia and valproate levels checked. Treatment includes discontinuing the drug and starting lactulose. L-carnitine can also be considered.
Single unprovoked seizure
single unprovoked seizure requires investigation with laboratory studies, MRI of the brain, and EEG to rule out underlying organic disease and estimate future seizure risk. Abnormal studies indicate a high risk of recurrence and usually require antiepileptics.
Para neoplastic cerebellar degeneration
A) PCD is most commonly associated with lung, gynecologic, and breast cancer.
B)Patients classically present with the acute onset of dizziness with nausea/vomiting, followed by cerebellar signs, dysarthria, and diplopia several days later.
C)Symptoms may progress over weeks to months and often precede a cancer diagnosis by years,
D) MRI may initially be normal but can demonstrate cerebellar atrophy with prominent cerebellar folia several months after symptom onset.
E)Cerebrospinal fluid analysis may show mild pleocytosis and elevated protein. Paraneoplastic antibodies (eg, anti-Yo, anti-Hu, anti-Ri) are helpful in confirming PCD, but negative results do not exclude the diagnosis.
F)Patients without a diagnosis of cancer should undergo workup for occult malignancy.
Medications overuse headache
Medication-overuse headache (MOH) can present in the setting of a primary chronic headache disorder. It needs to be addressed separately from the chronic headache disorder by the discontinuation of the offending analgesic agent and the introduction of a short oral steroid taper.
REM sleep behavior treatment
sleep environment to minimize injury (eg, removing sharp and breakable objects, placing a cushion next to the bed) .
Melatonin is preferred as first-line treatment due to its favorable side-effect profile.
Low-dose clonazepam is an effective augmentation or alternative therapy for refractory cases.
Atrial fibrillation anticoagulation in patients with high risk of bleeding
In patients with atrial fibrillation who are at high risk of stroke and cannot tolerate oral anticoagulation therapy, left atrial appendage occlusion is effective for stroke prevention.
Occlusion can be achieved percutaneously with a self-expanding device that is implanted in the left atrial appendage or with surgical closure.
It is important to note that oral anticoagulation is recommended for the first 45 days after device occlusion of the left atrial appendage
Transverse myelitis
Presentation
Rare inflammatory disorder causing segmental spinal cord injury. Most cases of TM are idiopathic, likely due to an autoimmune process following a viral infection (50% of cases).
Patients present initially with spinal shock - lower-extremity weakness, flaccidity, areflexia, and absent Babinski sign. There will be a sensory level to all primary sensory modalities. Bowel and bladder dysfunction are present. Some patients also complain of a “band-like” squeezing pain. After 1 week, patients usually develop spasticity, hyperreflexia, Babinski sign, and clonus.
Transverse myelitis
Diagnosis and treatment
Diagnosis is suggested by magnetic resonance imaging with contrast, which shows enhancing cord segments with surrounding edema. Cerebrospinal fluid analysis usually shows elevated protein, moderate lymphocytosis, normal glucose, and no oligoclonal bands. Treatment is typically supportive (physical therapy). Intravenous corticosteroids can sometimes help patients with an autoimmune component of the disease.
Recovery usually occurs within 3 months, with up to 40% of patients experiencing some residual disability.